LIBRAX®


Tablets
scheduling status
S5
registration number
B/11.2/994
What LIBRAX® contains
LIBRAX® contains 5 mg 7-Chloro-2-N-methylamino-5-phenyl-3H-1,4-benzodiazepine-4-oxide (chlordiazepoxide) active substances of Librium (Trademark) and 2,5 mg 1-methyl-3-benziloyloxyquinu-clidinium bromide (clidinium bromide) per sugar-coated tablet.
other ingredients
Core: Lactose anhydrous White corn starch Talc Magnesium stearate Sugar-coating: Acacia gum spray-dried Indigo carmine 85 % Yellow iron oxide Rice starch Oil of paraffin of low viscosity Paraffinum sodium FP 50/52 Crystallized sugar Talcum Luzenac 00.
Therapeutic classification
A03CA02.
© 2026 SAHPRA. ALL RIGHTS RESERVED